Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

被引:66
|
作者
Bradley, Walter G. [1 ]
Borenstein, Amy R. [2 ]
Nelson, Lorene M. [3 ]
Codd, Geoffrey A. [4 ]
Rosen, Barry H. [5 ]
Stommel, Elijah W. [6 ]
Cox, Paul Alan [7 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
[2] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA
[3] Stanford Univ, Sch Med, Dept Hlth & Res Policy, Palo Alto, CA 94304 USA
[4] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland
[5] US Geol Survey, Off Reg Execut, Orlando, FL USA
[6] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH USA
[7] Inst Ethnomed, Jackson, WY USA
关键词
Amyotrophic lateral sclerosis; BMAA; cyanobacteria; epidemiology; environmental toxicants; METHYLAMINO-L-ALANINE; SCLEROSIS/PARKINSONISM-DEMENTIA COMPLEX; TRANSFER-RNA SYNTHETASE; MOTOR-NEURON DISEASE; PARKINSONISM-DEMENTIA; AMINO-ACID; TOXIC CYANOBACTERIA; CHAMORRO PEOPLE; NEUROTOXIN BMAA; GUAM;
D O I
10.3109/21678421.2012.750364
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is a broad scientific consensus that amyotrophic lateral sclerosis (ALS) is caused by gene-environment interactions. Mutations in genes underlying familial ALS (fALS) have been discovered in only 5-10% of the total population of ALS patients. Relatively little attention has been paid to environmental and lifestyle factors that may trigger the cascade of motor neuron death leading to the syndrome of ALS, although exposure to chemicals including lead and pesticides, and to agricultural environments, smoking, certain sports, and trauma have all been identified with an increased risk of ALS. There is a need for research to quantify the relative roles of each of the identified risk factors for ALS. Recent evidence has strengthened the theory that chronic environmental exposure to the neurotoxic amino acid beta-N-methylamino-L-alanine (BMAA) produced by cyanobacteria may be an environmental risk factor for ALS. Here we describe methods that may be used to assess exposure to cyanobacteria, and hence potentially to BMAA, namely an epidemiologic questionnaire and direct and indirect methods for estimating the cyanobacterial load in ecosystems. Rigorous epidemiologic studies could determine the risks associated with exposure to cyanobacteria, and if combined with genetic analysis of ALS cases and controls could reveal etiologically important gene-environment interactions in genetically vulnerable individuals.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [31] Physical Activity as a Risk Factor for Amyotrophic Lateral Sclerosis
    Shaw, Pamela J.
    Cooper-Knock, Johnathan
    NEUROLOGY, 2024, 103 (02)
  • [32] Executive dysfunction affects word list recall performance: Evidence from amyotrophic lateral sclerosis and other neurodegenerative diseases
    Consonni, Monica
    Rossi, Stefania
    Cerami, Chiara
    Marcone, Alessandra
    Iannaccone, Sandro
    Cappa, Stefano Francesco
    Perani, Daniela
    JOURNAL OF NEUROPSYCHOLOGY, 2017, 11 (01) : 74 - 90
  • [33] Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-analysis of epidemiological studies Pesticide exposure as a risk factor for ALS
    Malek, Angela M.
    Barchowsky, Aaron
    Bowser, Robert
    Youk, Ada
    Talbott, Evelyn O.
    ENVIRONMENTAL RESEARCH, 2012, 117 : 112 - 119
  • [34] Exposure to hazardous air pollutants and the risk of amyotrophic lateral sclerosis
    Malek, Angela M.
    Barchowsky, Aaron
    Bowser, Robert
    Heiman-Patterson, Terry
    Lacomis, David
    Rana, Sandeep
    Youk, Ada
    Talbott, Evelyn O.
    ENVIRONMENTAL POLLUTION, 2015, 197 : 181 - 186
  • [35] AMYOTROPHIC-LATERAL-SCLEROSIS AND OTHER MOTOR-NEURON DISEASES
    LEIGH, PN
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1991, 4 (04): : 586 - 596
  • [36] AMYOTROPHIC-LATERAL-SCLEROSIS AND OTHER MOTOR-NEURON DISEASES
    LEIGH, PN
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1990, 3 (04): : 567 - 575
  • [37] Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases
    Alisky, JM
    Davidson, BL
    HUMAN GENE THERAPY, 2000, 11 (17) : 2315 - 2329
  • [38] Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
    David Devos
    Z. Ioav Cabantchik
    Caroline Moreau
    Véronique Danel
    Laura Mahoney-Sanchez
    Hind Bouchaoui
    Flore Gouel
    Anne-Sophie Rolland
    James A. Duce
    Jean-Christophe Devedjian
    Journal of Neural Transmission, 2020, 127 : 189 - 203
  • [39] Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis
    Fang, Fang
    Kamel, Freya
    Sandler, Dale P.
    Sparen, Par
    Ye, Weimin
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : 1281 - 1286
  • [40] Mitochondria and neurodegenerative diseases - Is there a link? The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis (ALS)
    Lindal, S
    ULTRASTRUCTURAL PATHOLOGY, 2002, 26 (01) : 1 - 2